Skip to main content
OpenTrials

Clinical trial condition

Uterine Neoplasms

Explore clinical trials studying Uterine Neoplasms. Study availability and eligibility vary by location and protocol.

2,256 public trials 565 recruiting studies
Refine in advanced search Browse all conditions

Uterine Neoplasms trial results

Active, Not Recruiting

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

NCT06003231

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +24 more
Locations
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Gilbert, Arizona, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Glendale, Arizona, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Mesa, Arizona, United States
View all 96 locations
View Trial Details
Active, Not Recruiting

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

NCT06607185

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in Spain

NCT06746116

Conditions
Advanced or Recurrent Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Research Site A Coruña, Spain
  • Research Site Alicante, Spain
  • Research Site Barakaldo, Spain
  • Research Site Barcelona, Spain
View all 24 locations
View Trial Details
Active, Not Recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

NCT05078047

Conditions
Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
Locations
  • Institut de cancérologie de l'Ouest Angers, France
  • Clinique Sainte Catherine Avignon, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • CHU Bordeaux - Hôpial Saint André Bordeaux, France
View all 33 locations
View Trial Details
Active, Not Recruiting

A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors

NCT06533059

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Cancer, +36 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Sarasota, Florida, United States
  • Research Site Boston, Massachusetts, United States
View all 31 locations
View Trial Details
Active, Not Recruiting

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

NCT05787587

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Cancer, +44 more
Locations
  • HonorHealth Research Institute Phoenix, Arizona, United States
  • The Angeles Clinic Los Angeles, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • California Pacific Medical Center San Francisco, California, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer

NCT05634499

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
  • Minnesota Oncology Minneapolis Minneapolis, Minnesota, United States
  • Englewood Health/Hematology Oncology Practice of Englewood (HOPE) Englewood, New Jersey, United States
View Trial Details
Active, Not Recruiting

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)

NCT06611540

Conditions
Cervical Carcinoma, Communicable Diseases, DNA Virus Infections, +23 more
Locations
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • UofL Health Medical Center Northeast Louisville, Kentucky, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
  • Minneapolis VA Medical Center Minneapolis, Minnesota, United States
View Trial Details

Related conditions